Skip to main content
. 2015 Jul 6;5:11951. doi: 10.1038/srep11951

Figure 5. Hemolytic and cytotoxic effects of VG16KRKP.

Figure 5

(A) Bar plot showing percentage of hemolysis of human RBC upon addition of increasing concentrations of VG16KRKP. (B) Bar plot showing percentage viability of human fibrosarcoma cell line upon treatment with increasing concentrations of VG16KRKP.